🚀 VC round data is live in beta, check it out!
Neurones Valuation Multiples
Discover revenue and EBITDA valuation multiples for Neurones and similar public comparables like Asseco SEE, transcosmos, Future Corporation, Bytes Technology Group and more.
Neurones Overview
About Neurones
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.
Founded
1984
HQ
Employees
7.1K
Website
Sectors
Financials (LTM)
EV
$675M
Neurones Financials
Neurones reported last 12-month revenue of $997M and EBITDA of $108M.
In the same LTM period, Neurones generated $108M in EBITDA and $62M in net income.
Revenue (LTM)
Neurones P&L
In the most recent fiscal year, Neurones reported revenue of $929M and EBITDA of $123M.
Neurones expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $997M | XXX | $929M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $581M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 63% | XXX | XXX | XXX |
| EBITDA | $108M | XXX | $123M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 13% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $62M | XXX | $60M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Neurones Stock Performance
Neurones has current market cap of $958M, and enterprise value of $675M.
Market Cap Evolution
Neurones' stock price is $39.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $675M | $958M | 0.0% | XXX | XXX | XXX | $2.48 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNeurones Valuation Multiples
Neurones trades at 0.7x EV/Revenue multiple, and 6.2x EV/EBITDA.
EV / Revenue (LTM)
Neurones Financial Valuation Multiples
As of March 16, 2026, Neurones has market cap of $958M and EV of $675M.
Equity research analysts estimate Neurones' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Neurones has a P/E ratio of 15.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $958M | XXX | $958M | XXX | XXX | XXX |
| EV (current) | $675M | XXX | $675M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 6.2x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBIT | 7.6x | XXX | 7.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.2x | XXX | XXX | XXX |
| P/E | 15.5x | XXX | 15.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 8.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Neurones Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Neurones Margins & Growth Rates
Neurones' revenue in the last 12 month grew by 5%.
Neurones' revenue per employee in the last FY averaged $0.1M.
Neurones' rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Neurones' rule of X is 23% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Neurones Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | (14%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 53% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Neurones Public Comps
See public comps and valuation multiples for other IT Consulting comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Asseco SEE | XXX | XXX | XXX | XXX | XXX | XXX |
| transcosmos | XXX | XXX | XXX | XXX | XXX | XXX |
| Future Corporation | XXX | XXX | XXX | XXX | XXX | XXX |
| Bytes Technology Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Systena | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Neurones M&A Activity
Neurones acquired XXX companies to date.
Last acquisition by Neurones was on XXXXXXXX, XXXXX. Neurones acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Neurones
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNeurones Investment Activity
Neurones invested in XXX companies to date.
Neurones made its latest investment on XXXXXXXX, XXXXX. Neurones invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Neurones
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Neurones
| When was Neurones founded? | Neurones was founded in 1984. |
| Where is Neurones headquartered? | Neurones is headquartered in France. |
| How many employees does Neurones have? | As of today, Neurones has over 7K employees. |
| Who is the CEO of Neurones? | Neurones' CEO is Luc de Chammard. |
| Is Neurones publicly listed? | Yes, Neurones is a public company listed on Euronext Paris. |
| What is the stock symbol of Neurones? | Neurones trades under NRO ticker. |
| When did Neurones go public? | Neurones went public in 2000. |
| Who are competitors of Neurones? | Neurones main competitors are Asseco SEE, transcosmos, Future Corporation, Bytes Technology Group. |
| What is the current market cap of Neurones? | Neurones' current market cap is $958M. |
| What is the current revenue of Neurones? | Neurones' last 12 months revenue is $997M. |
| What is the current revenue growth of Neurones? | Neurones revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Neurones? | Current revenue multiple of Neurones is 0.7x. |
| Is Neurones profitable? | Yes, Neurones is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Neurones? | Neurones' last 12 months EBITDA is $108M. |
| What is Neurones' EBITDA margin? | Neurones' last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Neurones? | Current EBITDA multiple of Neurones is 6.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.